Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
Pratteln, Switzerland, June 10, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its partner Sperogenix Therapeutics has launched a paid-for Early…
